| Abnormal Uterine Bleeding in Adolescents | Selin ELMAOĞULLARI,ZEHRA AYCAN | 191–197 |
| Prevalence and Related Factors of Euthyroid Sick Syndrome in Children with Untreated Cancer According to Two Different Criteria | Ali DUYU,ELVAN ÇAĞLAR ÇITAK,Erdem AK,SERHAN KÜPELİ,Begül YAĞCI KÜPELİ,İBRAHİM BAYRAM,GÜLAY SEZGİN,Gülçin ESKENDARİ,KEREM SEZER | 198–205 |
| A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations | Aslı Derya KARDELEN,Güven TOKSOY,FİRDEVS BAŞ,Zehra Yavaş ABALI,Genco GENÇAY,ŞÜKRAN POYRAZOĞLU,Rüveyde BUNDAK,Umut ALTUNOĞLU,Şahin AVCI,Adam NAJAFLI,ZEHRA OYA UYGUNER,BİRSEN KARAMAN,SEHER BAŞARAN,FATMA FEYZA DARENDELİLER | 206–215 |
| Parental Perception of Terminology of Disorders of Sex Development in Western Turkey | Sibel TİRYAKİ,ALİ TEKİN,İSMAİL YAĞMUR,SAMİM ÖZEN,Burcu ÖZBARAN,RUHSAR DAMLA GÖKŞEN ŞİMŞEK,ŞÜKRAN DARCAN,İBRAHİM ULMAN,Ali AVANOĞLU | 216–222 |
| Investigation of MKRN3 Mutation in Patients with Familial Central Precocious Puberty | ZEHRA AYCAN,ŞENAY SAVAŞ ERDEVE,SEMRA ÇETİNKAYA,Erdal KURNAZ,Melikşah KESKİN,Nursel MURATOĞLU ŞAHİN,Elvan BAYRAMOĞLU,Gülay CEYLANER | 223–229 |
| A Synopsis of Current Practice in the Diagnosis and Management of Patients with Turner Syndrome in Turkey: A Survey of 18 Pediatric Endocrinology Centers | Ahmet UÇAR,AYHAN ABACI,MUSTAFA ÖZGÜR PİRGON,BUMİN NURİ DÜNDAR,FİLİZ TÜTÜNCÜLER KÖKENLİ,GÖNÜL ÇATLI,AHMET ANIK,Aylin KILINÇ UĞURLU,Atilla BÜYÜKGEBİZ | 230–238 |
| Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty | Nursel MURATOĞLU ŞAHİN,ASİYE UĞRAŞ DİKMEN,SEMRA ÇETİNKAYA,ZEHRA AYCAN | 239–246 |
| Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood? | EMİNE ÇAMTOSUN,ZEYNEP ŞIKLAR,MERİH BERBEROĞLU | 246–255 |
| Nationwide Study of Turner Syndrome in Ukrainian Children: Prevalence, Genetic Variants and Phenotypic Features | Nataliya ZELİNSKA,Iryna SHEVCHENKO,Evgenia GLOBA | 256–263 |
| Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life | FİLİZ MİNE ÇİZMECİOĞLU,Jeremy Huw JONES,Wendy Forsyth PATERSON,Sakina KHERRA,Mariam KOURİME,Ruth MCGOWAN,M. Guftar SHAİKH,Malcolm DONALDSON | 264–273 |
| Severe Early Onset Obesity due to a Novel Missense Mutation in Exon 3 of the Leptin Gene in an Infant from Northwest India | Devi DAYAL,Keerthivasan SEETHARAMAN,Inusha PANİGRAHİ,Balasubramaniyan MUTHUVEL,Ashish AGARWAL | 274–278 |
| Sirolimus-Induced Hepatitis in Two Patients with Hyperinsulinemic Hypoglycemia | Belma HALİLOĞLU,Heybet TÜZÜN,Sarah E FLANAGAN,Muhittin ÇELİK,Avni KAYA,Sian ELLARD,Mehmet Nuri ÖZBEK | 279–283 |
| A Novel Variant c.97C>T of the Growth Hormone Releasing Hormone Receptor Gene Causes Isolated Growth Hormone Deficiency Type Ib | Assimina GALLİ-TSİNOPOULOU,Eleni P. KOTANİDOU,Aggeliki N. KLEİSARCHAKİ,Rivka KAULİ,Zvi LARON | 284–288 |
| Peripheral Neuropathy as a Complication of Diabetic Ketoacidosis in a Child with Newly Diagnosed Diabetes Type 1: A Case Report | Marta BASZYNSKA-WİLK,Marta WYSOCKA-MİNCEWİCZ,Anna ŚWİERCZ,Jolanta ŚWİDERSKA,Magdalena MARSZAł,Mieczysław SZALECKİ | 289–293 |
| Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine | Victoria CAMPBELL,Rachel BECKETT,Noina ABİD,Susannah HOEY | 294–298 |
| The Importance of Gestation-Adjusted Birthweight Centile in Assessment of Fetal Growth in Metabolic Conditions | Caroline OVADİA,Hanns-Ulrich MARSCHALL,Catherine WİLLİAMSON | 299–300 |